Amrutanjan Health Care Limited

Web: amrutanjan.com NSE: AMRUTANJAN BSE: 590006 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

506 14(-3%)

Near 52W Low of 486

Volume

25k as on 23, Jun

Open

744

High

744

Low

727

520

VWAP

553

52 Week High

791

52 Week Low

486

Viand Research Rating

Quality Score

0/100

Growth Score

0/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,463

No. of Shares

2.89

P/E

44.29

P/B

7.3

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

16.47

ROCE

Profit Growth

Listing Date

02-Jan-15

Promoter Holding

46.52%

FII Holding

2.17%

DII Holding

12.66%

Price Chart

Price Performance

1 Week2%

1 Month1%

3 Months7%

6 Months0%

1 Year0%

YTD0%

Moving Average

5 Day SMA546

10 Day SMA551

20 Day SMA553

30 Day SMA556

50 Day SMA556

61 Day SMA549

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	566	552	561	567
Resistance 2	561	551	556	561
Resistance 1	555	550	554	555
Pivot Point	549	549	549	549
Support 1	543	548	545	544
Support 2	537	547	542	538
Support 3	531	546	537	532

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,66,156	1943	1%	4%	19%	14%	37	57.7	0.07	11509
2	DIVISLAB	1,91,668	7220	0%	7%	21%	10%	69	57.7	0	2568
3	TORNTPHARM	1,68,504	4979	4%	10%	26%	38%	72	57.7	1.79	2138
4	APOLLOHOSP	1,26,451	8794	0%	3%	29%	18%	58	57.7	0.9	2003
5	CIPLA	1,13,825	1409	1%	2%	7%	8%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,902	1112	3%	1%	26%	14%	20	57.7	0.46	5124
7	LUPIN	1,08,410	2371	3%	0%	11%	22%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,104	1080	1%	0%	9%	16%	0	57.7	0.32	1442
9	MANKIND	1,03,745	2512	1%	1%	19%	4%	49	57.7	0.39	1938
10	DRREDDY	96,236	1153	5%	13%	7%	10%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(0.01) 46.52%	(-4.11) 46.52%	(0.01) 50.58%	(0.01) 50.59%	(0.01) 50.59%	(0.61) 50.59%	(0.01) 50.03%	(0.01) 50.03%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%	(0.01) 50.02%
FIIs	(-0.11) 2.17%	(-0.11) 2.27%	(0.01) 2.38%	(0.11) 2.41%	(0.01) 2.30%	(0.01) 2.30%	(0.81) 2.34%	(0.21) 1.55%	(0.61) 1.38%	(0.11) 0.80%	(0.11) 0.75%	(0.01) 0.69%	(-0.11) 0.68%	(-0.11) 0.76%	(-0.61) 0.87%	(0.01) 1.42%	(-0.41) 1.43%	(0.31) 1.83%	(0.01) 1.53%
DIIs	(-0.31) 12.66%	(0.11) 13.00%	(0.21) 12.90%	(1.31) 12.70%	(0.31) 11.41%	(0.51) 11.13%	(3.31) 10.60%	(0.01) 7.32%	(0.01) 7.29%	(0.11) 7.24%	(-0.11) 7.10%	(0.01) 7.22%	(0.81) 7.18%	(0.11) 6.39%	(0.11) 6.30%	(0.01) 6.16%	(0.01) 6.14%	(-0.81) 6.14%	(0.01) 6.94%
Public	38.61%	38.18%	38.16%	38.34%	39.75%	40.01%	40.50%	40.47%	40.66%	41.19%	41.39%	41.87%	41.93%	42.65%	42.62%	42.21%	42.23%	41.90%	41.41%
No. of Shareholders	45,805	46,675	47,954	49,431	51,674	53,856	54,536	57,169	62,664	68,404	72,002	71,428	69,947	72,104	71,064	66,173	67,323	61,367	41,640

Quarterly Results

Profit and Loss

	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Sales	177	158	134	131	136	101	86	87	71	69	67
Sales Growth %	12.1%	17.4%	2.8%	-4.2%	35.1%	17.3%	-1.1%	22.4%	3.4%	3.3%	-
Expenses	145	134	112	113	118	88	76	182	60	53	53
Operating Profit	31	24	22	17	18	13	10	-95	11	16	13
OPM %	18	15	16	13	13	13	12	-109	16	23	20
Other Income	5	4	3	4	4	5	10	220	0	-2	1
Interest	0	1	2	2	3	1	0	0	1	1	1
Depreciation	3	3	4	4	3	2	1	2	2	2	3
Profit before tax	33	24	19	15	16	15	19	123	9	11	11
Tax %	37	38	36	35	39	34	38	25	42	46	45
Net Profit	21	15	12	10	10	10	11	92	5	6	6
Net Profit Growth %	40%	25%	20%	-	-	-9.1%	-88%	1740%	-16.7%	-	-
EPS in Rs	7.05	5.1	4.26	3.47	3.32	0	0	29.8	0	0	0
Dividend Payout %	27	34	38	43	45	45	40	19	45	32	22

Cash Flows

	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Cash from Operating Activity	21	18	17	9	4	6	11	6	5	11	10
Cash from Investing Activity	4	-5	16	13	14	-29	-47	89	-8	-4	3
Cash from Financing Activity	-13	-12	-14	-14	-27	20	-8	-30	-2	-1	-12
Net Cash Flow	12	1	20	8	-9	-4	-43	65	-5	6	1

Balance Sheet

	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006
Equity Capital	3	3	3	3	3	3	3	3	3	3	3
Reserves	106	92	86	79	74	98	94	90	23	20	15
Borrowings	2	2	8	15	22	30	1	1	8	8	6
Other Liabilities	29	26	23	27	25	26	20	17	14	10	13
Total Liabilities	140	124	120	124	124	157	118	111	48	41	37
Fixed Assets	29	24	27	30	33	52	16	16	20	13	16
CWIP	1	4	1	1	1	0	7	2	3	3	0
Investments	9	9	9	25	29	42	46	0	0	0	0
Other Assets	102	87	83	69	62	62	50	92	25	26	21
Total Assets	140	124	120	124	124	157	118	111	48	41	37

Delivery

#	Date	505 14% 577	Value (Cr)	Q/T 24	Del 57	Del 6
1	24-Jul	509	3	26	75	3
2	23-Jul	520	2	14	51	1
3	22-Jul	529	2	16	66	1
4	21-Jul	539	1	12	67	1
5	20-Jul	547	3	20	35	1
6	17-Jul	538	1	15	63	1
7	16-Jul	535	1	16	58	1
8	15-Jul	534	2	25	63	1
9	14-Jul	536	3	40	78	2
10	13-Jul	540	1	21	57	1
11	10-Jul	538	5	23	53	3
12	9-Jul	536	1	13	50	1
13	8-Jul	538	2	13	47	1
14	7-Jul	538	9	28	57	5
15	6-Jul	532	19	34	64	12
16	3-Jul	538	5	28	73	3
17	2-Jul	543	3	19	59	2
18	1-Jul	551	3	14	59	2
19	30-Jun	548	1	17	70	1
20	29-Jun	540	2	27	73	1
21	25-Jun	537	1	16	53	1
22	24-Jun	536	6	20	60	4
23	23-Jun	554	1	16	61	1
24	22-Jun	549	1	18	64	1
25	19-Jun	545	3	36	77	2
26	18-Jun	546	1	14	52	1
27	17-Jun	534	5	14	69	3
28	16-Jun	541	5	31	77	4
29	15-Jun	555	1	20	68	1
30	12-Jun	558	1	21	77	1
31	11-Jun	562	2	17	54	1
32	10-Jun	569	2	18	70	1
33	9-Jun	561	0	9	49	0
34	8-Jun	557	1	20	80	1
35	5-Jun	552	1	15	69	1
36	4-Jun	543	2	15	62	1
37	3-Jun	547	1	16	56	1
38	2-Jun	556	1	16	71	1
39	1-Jun	560	1	17	58	1
40	29-May	559	1	12	63	1
41	27-May	560	0	10	52	0
42	26-May	558	1	14	68	0
43	25-May	563	1	15	54	1
44	22-May	557	1	20	70	1
45	21-May	549	1	20	73	1
46	20-May	550	0	13	51	0
47	19-May	557	1	9	52	0
48	18-May	558	1	12	50	0
49	15-May	555	2	19	60	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
24-Jul	1,463c	35c	2.34
23-Jul	1,498c	27c	1.74
22-Jul	1,525c	35c	2.22
21-Jul	1,559c	3c	0.21
17-Jul	1,556c	9c	0.60
16-Jul	1,546c	6c	0.38
15-Jul	1,541c	20c	1.25
14-Jul	1,560c	1c	0.08
13-Jul	1,562c	21c	1.31
10-Jul	1,582c	33c	2.10
09-Jul	1,550c	4c	0.28
08-Jul	1,554c	14L	0.01
07-Jul	1,554c	18c	1.14
06-Jul	1,537c	52c	3.29
02-Jul	1,589c	43L	0.03
01-Jul	1,589c	14c	0.87
30-Jun	1,576c	8c	0.49
29-Jun	1,568c	18c	1.18
26-Jun	1,550c	19c	1.18
25-Jun	1,568c	7c	0.47
24-Jun	1,561c	43c	2.69
23-Jun	1,604c	14c	0.87
22-Jun	1,590c	17c	1.10
19-Jun	1,573c	25c	1.59
17-Jun	1,548c	15c	0.93
16-Jun	1,563c	42c	2.62
15-Jun	1,605c	11c	0.70
12-Jun	1,616c	18c	1.10
11-Jun	1,634c	0	0

Stock Checklist

Price is below from 52 week high low average: 87%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 3 fund house(s) as of Jul26 · Total value ₹199 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
DSP Mutual Fund	2	0.46%	-	139.4
ICICI Prudential Mutual Fund	2	2.00%	-0.01%	63.6
Sundaram Mutual Fund	4	-0.07%	-0.01%	-4.4

Amrutanjan Health Care Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements